In Phase A, individuals will get various doses and schedules of oral ABBV-744 tablet to detect Risk-free dosing program. Extra members are going to be enrolled on the determined monotherapy dosign program. In Phase B, participants will receive oral ruxolitinib and ABBV-744 is going to be given as "include-on" therapy. https://georgec332owi4.blogsvila.com/profile